title: Hypertension and sleep apnea-hypopnea syndrome: changes in echocardiographic abnormalities depending on the presence of hypertension and treatment with CPAP.
abstract: BACKGROUND
  Sleep apnea-hypopnea syndrome (SAHS) is an emerging disease with high prevalence. There is controversy as to whether cardiac abnormalities are due to the disease itself or to the arterial hypertension frequently associated with this disease.
  
  
  OBJECTIVE
  To analyze echocardiographic abnormalities in a population of SAHS patients depending on the presence or absence of hypertension at the time of diagnosis and after six months of treatment with continuous positive airway pressure (CPAP).
  
  
  METHODS
  We studied 85 consecutive patients diagnosed with SAHS who required treatment with CPAP (Hypertensive: 43, nonhypertensive: 42). We performed a baseline echocardiogram after six months of treatment. We analyzed morphological (wall thickness, diameters, ejection fraction) and functional (peak E- and A-wave velocities, deceleration time, Tei index) parameters of the left and right ventricles.
  
  
  RESULTS
  Hypertensive patients were older and had higher blood pressure values, but there were no differences between groups in other clinical parameters. The hypertensive group had greater septal thickness (hypertensive: 12.1+/-2.3; nonhypertensive: 10.8+/-2.1mm; p=0.01). There were also differences in impairment of left (hypertensiveHT: 92.9%, nonhypertensive: 65%, p=0.002) and right (hypertensive: 74.4%, nonhypertensive: 42.1%, p=0.006) ventricular filling. After six months of treatment, an improvement of the myocardial performance index was noted in nonhypertensive patients (baseline Tei: 0.55+/-0.1 vs. 6-month Tei: 0.49+/-0.1; p=0.01), whereas no significant change was observed in hypertensive patients.
  
  
  CONCLUSIONS
  Cardiac abnormalities in SAHS patients are increased in the presence of associated hypertension. Treatment with CPAP for six months improves cardiac abnormalities in nonhypertensive patients but not in hypertensive patients.
authors.affiliation: Research Foundation, La Fe University Hospital, Avda. Campanar 19. 46009, Valencia, Spain. moro@uv.es
authors.forename: Jose A
authors.initials: JA
authors.lastname: Moro
authors.forename: Luis
authors.initials: L
authors.lastname: Almenar
authors.forename: Estrella
authors.initials: E
authors.lastname: Fernández-Fabrellas
authors.forename: Silvia
authors.initials: S
authors.lastname: Ponce
authors.forename: Rafael
authors.initials: R
authors.lastname: Blanquer
authors.forename: Antonio
authors.initials: A
authors.lastname: Salvador
mesh_terms: D000328:Adult; D001783:Blood Flow Velocity; D045422:Continuous Positive Airway Pressure; D015150:Echocardiography, Doppler / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000453:epidemiology; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D015588:Observer Variation; D015995:Prevalence; D012891:Sleep Apnea Syndromes / Q000150:complications* / Q000453:epidemiology / Q000628:therapy*; D013318:Stroke Volume; D016896:Treatment Outcome